SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
SEC Accession No. 0001562762-15-000080
Filing Date
2015-03-13
Accepted
2015-03-13 16:47:44
Documents
14
Period of Report
2014-12-31
Filing Date Changed
2015-03-13

Document Format Files

Seq Description Document Type Size
1 10-K cort-20141231x10k.htm 10-K 2209864
2 EX-10.41 cort-20141231ex104178fd5.htm EX-10.41 91232
3 EX-23.1 cort-20141231ex231f3648a.htm EX-23.1 11529
4 EX-31.1 cort-20141231ex311e798c7.htm EX-31.1 17068
5 EX-31.2 cort-20141231ex312961d1f.htm EX-31.2 17288
6 EX-32.1 cort-20141231ex3212065ec.htm EX-32.1 9294
7 EX-32.2 cort-20141231ex3222c87d5.htm EX-32.2 9531
8 GRAPHIC cort-20141231x10kg001.jpg GRAPHIC 54628
  Complete submission text file 0001562762-15-000080.txt   9664960

Data Files

Seq Description Document Type Size
9 EX-101.INS cort-20141231.xml EX-101.INS 1401076
10 EX-101.SCH cort-20141231.xsd EX-101.SCH 45565
11 EX-101.CAL cort-20141231_cal.xml EX-101.CAL 44890
12 EX-101.DEF cort-20141231_def.xml EX-101.DEF 163330
13 EX-101.LAB cort-20141231_lab.xml EX-101.LAB 389299
14 EX-101.PRE cort-20141231_pre.xml EX-101.PRE 313160
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50679 | Film No.: 15699940
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1